Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Passage Bio Inc
PASGCurrent price
0.65 USD
+0.017 USD (+2.72%)
Last closed
0.61 USD
Company
www.passagebio.com
ISIN
US7027121000
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
37 863 352 USD
Yield for 12 month
+8.37 %
1Y
3Y
5Y
10Y
15Y
PASG
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Address: One Commerce Square, Philadelphia, PA, United States, 19103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.75 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 721 000 USD
Last Year
-3 679 000 USD
Current Quarter
-800 000 USD
Last Quarter
-806 000 USD
Key Figures PASG
1 year
3 years
5 years
10 years
EBITDA
-84 650 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.48 %
PEG Ratio
–
Return On Equity TTM
-63.55 %
Wall Street Target Price
6.75 USD
Revenue TTM
–
Book Value
1.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.35 USD
Diluted Eps TTM
-1.35 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PASG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PASG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PASG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.8725
Price Book MRQ
0.4181
Financials PASG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PASG
For 52 weeks
0.54 USD
1.79 USD
50 Day MA
0.65 USD
Shares Short Prior Month
1 701 219
200 Day MA
1.01 USD
Short Ratio
6.41
Shares Short
1 682 395
Short Percent
3.27 %
BeatStart